Lenalidomide Plus Rituximab (R) in Non Follicular NHL

Clinical trial NCT01830478 · UNKNOWN

Trial details

NCT number: NCT01830478
Sponsor: Gruppo Italiano Studio Linfomi
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Indolent Non Hodgkin Lymphoma

Start date: 2009-04-01
Primary completion: 2010-12-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.